'Protein therapeutics' presentation slideshows

Protein (Bio)Technology; Industrial and Medical Perspectives

Protein (Bio)Technology; Industrial and Medical Perspectives. M. Kamran Azim, Ph.D. International Center for Chemical and Biological Sciences H.E.J. Research Institute of Chemistry, Dr. Panjwani Center for Molecular Medicine and Drug Research University of Karachi.

663 views • 41 slides

USING BIOMARKERS FOR EARLY PHASE DOSE SELECTION WITH PROTEIN ANTAGONIST DRUGS

USING BIOMARKERS FOR EARLY PHASE DOSE SELECTION WITH PROTEIN ANTAGONIST DRUGS. Ivan Nestorov ivan.nestorov@biogenidec.com. TALK FRAMEWORK. Setting the stage: introductions and definitions PK and binding as major early markers Biological activity as validation for binding Walk-through example

661 views • 27 slides

The Science and Ethics of Reproductive Cloning: Introduction to the Science California Science Center April 15, 2006

1.15k views • 25 slides

de novo Protein Design

de novo Protein Design. Presented by Alison Fraser, Christine Lee, Pradhuman Jhala, Corban Rivera. Outline. Introduction Computational methods used for sequence and structure Biophysical and structural characteristics of novel protein Conclusion. Introduction. Number of protein folds

836 views • 15 slides

World Insulin Analog Market by 2017

The world market for Insulin Analog products is estimated to be worth $168 billion by 2017, growing at a CAGR of 10.94% from 2012 to 2017. Key companies in the market include Genetech (U.S.), Amgen(U.S.), Roche (Switzerland), Eli Lilly (U.S.) etc.

386 views • 10 slides

Protein Therapeutics: a summary and pharmacological classification

Protein Therapeutics: a summary and pharmacological classification. Benjamin Leader, Quentin J. Baca and David E. Golan. Yiben Wang 11/16/11. Protein Therapeutics: -25,000-40,000 different genes in the human genome -Alternative splicing of genes -Post-translational modifications

290 views • 10 slides

Protein Therapeutics: a summary and pharmacological classification

Protein Therapeutics: a summary and pharmacological classification. Benjamin Leader, Quentin J. Baca and David E. Golan. Yiben Wang 11/16/11. Protein Therapeutics: -25,000-40,000 different genes in the human genome -Alternative splicing of genes -Post-translational modifications

121 views • 10 slides

Global Biologic Therapeutics Market Size, Analysis, Share

Biologic therapeutics include virus, therapeutic serum, toxin, allergenic product, antitoxin, blood component or derivative, vaccine, blood, protein (except any chemically synthesized polypeptide), or analogous product, or arsphenamine or derivative of arsphenamine (or any other trivalent organic arsenic compound), intended for the prevention, treatment, or cure of a disease or condition. These products differ from small molecules in terms of molecular weight, structure, synthesis, and immunogenicity. Biologic products are generally characterized by high molecular weight and complex structures. These products are usually derived from living entities and are less easily characterized compared to small molecules. These products are often susceptible to extreme temperatures and light. TechNavio's analysts forecast the Global Biologic Therapeutics market to grow at a CAGR of 8.22 percent over the period 2013-2018. Complete report is available at : http://www.researchbeam.com/global-biologic-therapeutics-2014-2018-market

225 views • 8 slides

Chinese Market for Brain Cancer Treatment Drugs

Analyze Future: Brain Cancer Treatment Drugs Markets in China To Get More Details @ http://www.analyzefuture.com/brain-cancer-treatment-drugs-in-china-market China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants.

264 views • 8 slides

Global Plasma Protein Therapeutics Market

Plasma protein therapeutics market has been perceived by Goldstein Research is likely to exhibit a CAGR of 7.34% over the forecast period of 2017-2025. The plasma protein therapeutics industry report includes market size, share, demand, trends, key players, growth drivers on the basis of regional segmentation

98 views • 8 slides

Protein Therapeutics Market- Global Share, Analysis

Protein therapeutics is artificially synthesized protein on large scale through genetically modified host cells that is used in treatment of chronic diseases such as cancer, diabetes and CVD. According to IMS Health Market Prognosis, the total market size of pharmaceutical industry was approximately $962.1 billion in 2012. This shows growth opportunities for protein therapeutics market. High efficiency of protein therapeutics with fewer side effects is driving the protein therapeutics market. For example, Approximately 17.7 adults consumed oral medication (Pills or insulin) for diabetes in 2011.

340 views • 5 slides

Global Protein Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. For more information inquire @ http://www.reportsnreports.com/contacts/InquiryBeforeBuy.aspx?name=444845

267 views • 5 slides

an introduction for Large-scale Protein Production

an introduction for Large-scale Protein Production

44 views • 3 slides

Large-Scale Protein Production

Large-Scale Protein ProductionLarge-Scale Protein Production

94 views • 3 slides

Protein Therapeutics Market Expected to Reach $217,591 Million, Globally, by 2023

Global Protein Therapeutics Market accounted for $140,109 million in 2016 and is anticipated to reach $217,591 million by 2023, registering a CAGR of 6.5% from 2017 to 2023.

34 views • 2 slides